NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vona Oncology

Vona Oncology

Private
Aurora, ColoradoHealthcare & Life Scienceshttps://vonaoncology.com/

Last Round

Grant

Nov 20, 2025

Total Funding Raised

$2.89M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vona Oncology is a biopharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer, ovarian cancer, and melanoma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

oncology therapeuticssmall molecule therapeuticstargeted therapytriple-negative breast cancerTNBCclinical stage biopharmafirst-in-class therapeuticdrug discoveryovarian cancermelanomahard-to-treat cancersIND-enabling studiesnon-dilutive fundingSBIR grantpharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vona Oncology Comps

Public and private peers based on sector, stage, and business model.

Vona Oncology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vona Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2025
GrantMay 20, 2021

Vona Oncology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2025

    Monthly visitors increased 222% MoM.

  • Nov 20, 2025

    $250K grant from Colorado Office of Economic Development and International Trade.

Vona Oncology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vona Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vona Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersAurora, Colorado
Employee Range2
Year Founded2018
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.